英力士苯领在2017 MEDTEC中国展上展出健康护理行业创新解决方案

2017-09-18 佚名 MedSci原创

-- 广泛的苯乙烯系列产品解决方案,包括K®树脂SBC,将在2017年MEDTEC中国展的B305展位上亮相
-- Novodur® HD M203FC G3:通过了生物相容性认证的玻纤增强ABS
-- Styrolux® 4G60:TPE专用滴斗料

上海2017年9月18日电 /美通社/ -- 苯乙烯行业全球领导者英力士苯领将于920日至22日在上海举办的2017MEDTEC中国展上展示其健康护理行业最新创新产品。

英力士苯领在健康护理行业持续努力,不断扩展产品范围,开发了几种前景广阔的创新技术和新产品。

“作为一个具有深厚的行业专长的全球化公司,英力士苯领与其合作伙伴精诚合作,提供成本低、外观卓越、性能一流的医疗解决方案”,英力士苯领大中华区健康护理主管Jerry Song说。“我们期待在MEDTEC中国展上迎接来自世界各地的医疗器械制造商和设计师,与他们讨论合作事宜,用我们的创新产品解决方案和完善的医疗服务组合携手在激烈的竞争中脱颖而出。”

在访问MEDTEC中国展英力士苯领展位时,参观者可以体验以下创新解决方案。

- K随着对全球K树脂苯乙烯-丁二烯共聚物(SBC)业务的收购,英力士苯领在其产品组合中增加了一个在健康护理行业获得广泛认可的品牌。K树脂KR03和K树脂BK10等牌号非常适合器械和包装方面的许多医疗用途。这类聚合物不仅易于加工、性能优异,而且满足医疗行业的许多要求。

大多数K树脂共聚物满足USP VI要求,可以通过γ射线、环氧乙烷气体或电子束灭菌,对物理和光学性能的影响较小。

- Novodur HD M203FC G3 是一种适合医疗应用的玻纤增强ABS,通过了生物相容性标准ISO 10993和USP VI相关认证。新牌号在大大增加刚性的同时还具有较高的流动性,使其成为医用穿刺器和在结构稳定性方面有特殊要求的首选材料。

材料符合法规要求,降低了器械制造商通过健康护理行业要求严苛且耗时的法规认可时存在的风险。对Novodur HD M203FC G3英力士苯领将提供“全套HD服务组合”,内容包括上述法规文件和长达36个月的变更通知(NOC)以及签署的长期供货合同。

- Styrolux 4G60 专为输液器滴斗而设计。Styrolux 4G60在硬度、弹性和透明度方面都表现卓越。该产品具有非常好的粘结性,非常适合滴斗的生产。该牌号的材料符合USP VI和ISO 10993标准的认证。

对Styrolux 4G60提供“基本HD服务组合”并签署长期供货合同。套餐包括长达12个月的NOC。

英力士苯领的健康护理行业产品范围广泛,包括透明聚合物(Terlux® HD、Zylar®、Clearblend®、Styrolux®、Styroflex®、K®树脂、Luran® HD、NAS®)、不透明聚合物(Novodur® HD、Lustran® (ABS))及食品级普通材料(Styrolution® PS、Terluran®)为医疗器械设计者提供广泛选择以及研发支持。

健康护理技术研讨会:

在展会期间,英力士苯领将主办一场研讨会,来分享医疗领域使用苯乙烯聚合物的新进展。欢迎所有的参观者和媒体前来参观。

  • 时间:2017年9月20日;下午13:30 - 14:00
  • 地点:新技术会议

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1652216, encodeId=740d16522168c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Apr 23 11:24:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693991, encodeId=fa2c1693991e8, content=<a href='/topic/show?id=f1341150875' target=_blank style='color:#2F92EE;'>#Medtec中国展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11508, encryptionId=f1341150875, topicName=Medtec中国展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29df29523511, createdName=skhzy, createdTime=Wed May 16 18:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987998, encodeId=2afa198e998e9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 24 06:24:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285417, encodeId=1b0e128541eb3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608045, encodeId=5fcf160804537, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=)]
    2018-04-23 shock_melon
  2. [GetPortalCommentsPageByObjectIdResponse(id=1652216, encodeId=740d16522168c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Apr 23 11:24:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693991, encodeId=fa2c1693991e8, content=<a href='/topic/show?id=f1341150875' target=_blank style='color:#2F92EE;'>#Medtec中国展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11508, encryptionId=f1341150875, topicName=Medtec中国展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29df29523511, createdName=skhzy, createdTime=Wed May 16 18:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987998, encodeId=2afa198e998e9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 24 06:24:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285417, encodeId=1b0e128541eb3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608045, encodeId=5fcf160804537, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1652216, encodeId=740d16522168c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Apr 23 11:24:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693991, encodeId=fa2c1693991e8, content=<a href='/topic/show?id=f1341150875' target=_blank style='color:#2F92EE;'>#Medtec中国展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11508, encryptionId=f1341150875, topicName=Medtec中国展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29df29523511, createdName=skhzy, createdTime=Wed May 16 18:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987998, encodeId=2afa198e998e9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 24 06:24:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285417, encodeId=1b0e128541eb3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608045, encodeId=5fcf160804537, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1652216, encodeId=740d16522168c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Apr 23 11:24:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693991, encodeId=fa2c1693991e8, content=<a href='/topic/show?id=f1341150875' target=_blank style='color:#2F92EE;'>#Medtec中国展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11508, encryptionId=f1341150875, topicName=Medtec中国展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29df29523511, createdName=skhzy, createdTime=Wed May 16 18:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987998, encodeId=2afa198e998e9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 24 06:24:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285417, encodeId=1b0e128541eb3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608045, encodeId=5fcf160804537, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1652216, encodeId=740d16522168c, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Apr 23 11:24:00 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693991, encodeId=fa2c1693991e8, content=<a href='/topic/show?id=f1341150875' target=_blank style='color:#2F92EE;'>#Medtec中国展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11508, encryptionId=f1341150875, topicName=Medtec中国展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29df29523511, createdName=skhzy, createdTime=Wed May 16 18:24:00 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1987998, encodeId=2afa198e998e9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Aug 24 06:24:00 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285417, encodeId=1b0e128541eb3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608045, encodeId=5fcf160804537, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Sep 20 05:24:00 CST 2017, time=2017-09-20, status=1, ipAttribution=)]